Bernard Lammek

1.4k total citations · 1 hit paper
59 papers, 1.2k citations indexed

About

Bernard Lammek is a scholar working on Social Psychology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bernard Lammek has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Social Psychology, 28 papers in Molecular Biology and 17 papers in Organic Chemistry. Recurrent topics in Bernard Lammek's work include Neuroendocrine regulation and behavior (38 papers), Chemical Synthesis and Analysis (20 papers) and Chemical Reaction Mechanisms (15 papers). Bernard Lammek is often cited by papers focused on Neuroendocrine regulation and behavior (38 papers), Chemical Synthesis and Analysis (20 papers) and Chemical Reaction Mechanisms (15 papers). Bernard Lammek collaborates with scholars based in Poland, Czechia and United States. Bernard Lammek's co-authors include Wilbur H. Sawyer, Maurice Manning, Janny Seto, Marian Kruszynski, Jaya Haldar, Adam Prahl, Krzysztof Bańkowski, Jiřina Slaninová, Zbigniew Grzonka and Maurice Manning and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Biopolymers.

In The Last Decade

Bernard Lammek

57 papers receiving 1.2k citations

Hit Papers

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethyleneprop... 1980 2026 1995 2010 1980 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Lammek Poland 16 747 518 301 254 237 59 1.2k
Hidekazu Kawashima Japan 26 329 0.4× 515 1.0× 149 0.5× 262 1.0× 338 1.4× 84 2.0k
Marian Kruszynski United States 13 617 0.8× 303 0.6× 244 0.8× 185 0.7× 203 0.9× 31 926
Marie‐Noëlle Balestre France 18 525 0.7× 707 1.4× 234 0.8× 359 1.4× 139 0.6× 22 1.1k
Susanne Trumpp-Kallmeyer France 19 444 0.6× 1.4k 2.8× 268 0.9× 752 3.0× 198 0.8× 26 2.2k
Jacky Marie France 29 291 0.4× 1.7k 3.2× 866 2.9× 620 2.4× 118 0.5× 59 2.8k
René Seyer France 15 276 0.4× 663 1.3× 143 0.5× 302 1.2× 41 0.2× 32 921
Aleksandra Olma Poland 17 798 1.1× 475 0.9× 295 1.0× 259 1.0× 207 0.9× 51 1.1k
Wieslaw A. Kliś United States 16 521 0.7× 439 0.8× 174 0.6× 159 0.6× 190 0.8× 31 875
I. L. Schwartz United States 22 358 0.5× 539 1.0× 101 0.3× 283 1.1× 102 0.4× 70 1.2k
Maurice Manning United States 12 475 0.6× 280 0.5× 186 0.6× 152 0.6× 135 0.6× 25 650

Countries citing papers authored by Bernard Lammek

Since Specialization
Citations

This map shows the geographic impact of Bernard Lammek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lammek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lammek more than expected).

Fields of papers citing papers by Bernard Lammek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lammek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lammek. The network helps show where Bernard Lammek may publish in the future.

Co-authorship network of co-authors of Bernard Lammek

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Lammek. A scholar is included among the top collaborators of Bernard Lammek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Lammek. Bernard Lammek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Borovičková, Lenka, et al.. (2011). Novel analogues of bradykinin conformationally restricted in the C‐terminal part of the molecule. Journal of Peptide Science. 17(5). 366–372. 1 indexed citations
3.
Kwiatkowska, Anna, et al.. (2009). Novel analogues of arginine vasopressin containing α‐2‐indanylglycine enantiomers in position 2. Journal of Peptide Science. 16(1). 15–20. 5 indexed citations
4.
Prahl, Adam, et al.. (2008). Analogues of AVP modified in theN‐terminal part of the molecule with Pip isomers: TFA‐catalysed peptide bond hydrolysis. Journal of Peptide Science. 15(3). 161–165. 5 indexed citations
5.
Bélanger, Simon, Veronica Bovenzi, Jérôme Côté, et al.. (2008). Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor. Peptides. 30(4). 777–787. 34 indexed citations
8.
Sikorska, Emilia, Magdalena J. Ślusarz, & Bernard Lammek. (2006). Conformational studies of vasopressin analogues modified with N‐methylphenylalanine enantiomers in dimethyl sulfoxide solution. Biopolymers. 82(6). 603–614. 10 indexed citations
9.
Podstawka, Edyta, Emilia Sikorska, Leonard M. Proniewicz, & Bernard Lammek. (2006). Raman and surface‐enhanced Raman spectroscopy investigation of vasopressin analogues containing 1‐aminocyclohexane‐1‐carboxylic acid residue. Biopolymers. 83(2). 193–203. 48 indexed citations
10.
Prahl, Adam, et al.. (2006). Analogs of arginine vasopressin modified in the N‐terminal part of the molecule with a conformationally constrained cis‐peptide bond motif. Journal of Peptide Science. 13(2). 128–132. 4 indexed citations
11.
Sikorska, Emilia, Magdalena J. Ślusarz, Rafał Ślusarz, Wioleta Kowalczyk, & Bernard Lammek. (2005). Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N‐methylphenylalanine enantiomers. Journal of Peptide Science. 12(1). 13–24. 7 indexed citations
12.
Kowalczyk, Wioleta, et al.. (2005). The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties. Journal of Peptide Science. 11(9). 584–588. 13 indexed citations
13.
Kowalczyk, Wioleta, et al.. (2004). Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments. Journal of Peptide Science. 11(2). 91–96. 3 indexed citations
14.
Prahl, Adam, et al.. (2004). Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties. European Journal of Medicinal Chemistry. 40(1). 63–68. 10 indexed citations
15.
Trzeciak, Henryk I., et al.. (2000). New bradykinin analogs in contraction of rat uterus,☆. Peptides. 21(6). 829–834. 17 indexed citations
16.
Lammek, Bernard, et al.. (1998). Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments. Journal of Peptide Research. 51(2). 149–154. 13 indexed citations
17.
Kaźmierkiewicz, Rajmund, Adam Liwo, & Bernard Lammek. (1995). Theoretical conformational analysis of three vasopressin antagonists with a modified cyclohexyl ring in the first thioacid residue. International journal of peptide & protein research. 45(5). 451–458. 1 indexed citations
18.
Manning, Maurice, Stoytcho Stoev, Krzysztof Bańkowski, et al.. (1992). Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin. Journal of Medicinal Chemistry. 35(2). 382–388. 35 indexed citations
19.
Wang, Yixin, Haralambos Gavras, Bernard Lammek, & Margaret Bresnahan. (1991). Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive rats. Journal of Hypertension. 9(9). 805–812. 19 indexed citations
20.
Manning, Maurice, Marian Kruszynski, Krzysztof Bańkowski, et al.. (1989). Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin. Journal of Medicinal Chemistry. 32(2). 382–391. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026